Gonal-f PEN 300 U.I./0.48 ml

Gonal-f PEN 300 U.I./0.48 ml is a medicine authorised by Swissmedic under authorisation number 56689. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 April 2004 and the authorisation is valid without a time limit. ATC code G03GA05 places the medicine in the group Sex hormones and modulators of the genital system.

  • Dispensing category A
  • Authorisation number 56689
  • ATC G03GA05
  • Biotechnological medicines
Authorisation data
Authorisation number56689
NameGonal-f PEN 300 U.I./0.48 ml
Full nameGonal-f PEN 300 U.I./0.48 ml, Injektionslösung
Authorisation holderMerck (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeG03GA05
First authorisation20 April 2004
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Gonal-f PEN 300 U.I./0.48 ml, InjektionslösungA20 April 2004
2Gonal-f PEN 450 U.I./0.72 ml, InjektionslösungA20 April 2004
3Gonal-f PEN 900 U.I./1.44 ml, InjektionslösungA20 April 2004

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
71SetG03GA0507.08.1.A
81SetG03GA0507.08.1.A
91SetG03GA0507.08.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Gonal-f PEN 300 U.I./0.48 ml authorised in Switzerland?

Yes. Gonal-f PEN 300 U.I./0.48 ml is authorised by Swissmedic under authorisation number 56689, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Gonal-f PEN 300 U.I./0.48 ml have?

Gonal-f PEN 300 U.I./0.48 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Gonal-f PEN 300 U.I./0.48 ml?

The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com